Literature DB >> 23678423

Radiofrequency ablation for treatment of atrial fibrillation.

Nasser Safaei1, Hossein Montazerghaem, Rasoul Azarfarin, Azin Alizadehasl, Hossein Alikhah.   

Abstract

INTRODUCTION: Atrial Fibrillation (AF) is the most common cardiac arrhythmia which represents a major public health problem. The main purpose of this research is to evaluate the Radiofrequency (RF) ablation effects in the patients with chronic AF scheduled for cardiac surgery because of different heart diseases.
METHODS: The descriptive and prospective study was conducted on 60 patients with AF scheduled for surgery along with RF ablation. The data were collected by questionnaire and included: patients' age, sex, NYHA class, operation type, past medical history, type and cause of valvular heart disease, preoperative ECG (electrocardiogram), duration of surgery, clamping time, cardiopulmonary bypass, and RF ablation time. RF ablation was followed by the main operation. The follow up examination, ECG, and echocardiography were performed 3 and 6 months after operation.
RESULTS: The mean age of patients was 48±10 years (18-71 years). Forty one patients had permanent AF and 19 had the persistent AF. The left ventricular ejection fraction was 48.27±9.75 percent before operation, and reached to 56.27±7.87 percent after the surgery (P<0.001). The mean NYHA class before the surgery was 2.83±0.68 which decreased to 1.34±0.46 6 months after the surgery with RF ablation (P<0.001). One patient (1.6%) died after surgery. Complete relief and freedom from AF recurrence was observed in 70% of patients in the mean follow up in 7 months after the surgery. The sinus rhythm with efficient atrial contraction was established in 100% of discharged patients.
CONCLUSION: RF ablation is an effective procedure to cure atrial fibrillation in patients undergoing cardiac surgeries.

Entities:  

Keywords:  Arrhythmia; Atrial fibrillation; Radiofrequency ablation; Sinus rhythm

Year:  2011        PMID: 23678423      PMCID: PMC3648962          DOI: 10.5681/bi.2011.023

Source DB:  PubMed          Journal:  Bioimpacts        ISSN: 2228-5652


  38 in total

Review 1.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Josep Brugada; Douglas L Packer; Riccardo Cappato; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; David E Haines; Michel Haissaguerre; Yoshito Iesaka; Warren Jackman; Pierre Jais; Hans Kottkamp; Karl Heinz Kuck; Bruce D Lindsay; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Andrea Natale; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Jeremy N Ruskin; Richard J Shemin
Journal:  Heart Rhythm       Date:  2007-04-30       Impact factor: 6.343

Review 2.  New ideas about atrial fibrillation 50 years on.

Authors:  Stanley Nattel
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

3.  Atrial fibrillation ablation: how far have we come?

Authors:  Carlo Pappone; Vincenzo Santinelli
Journal:  Rev Esp Cardiol       Date:  2009-10       Impact factor: 4.753

Review 4.  New technologies in atrial fibrillation ablation.

Authors:  J David Burkhardt; Andrea Natale
Journal:  Circulation       Date:  2009-10-13       Impact factor: 29.690

5.  Combined atrial fibrillation and mitral valve surgery using microwave technology.

Authors:  Michael Knaut; Sems Malte Tugtekin; Stefan Spitzer; Vassilios Gulielmos
Journal:  Semin Thorac Cardiovasc Surg       Date:  2002-07

6.  Impact of Cox maze procedure on outcome in patients with atrial fibrillation and mitral valve disease.

Authors:  Ko Bando; Junjiro Kobayashi; Yoshio Kosakai; Mitsuhiro Hirata; Yoshikado Sasako; Satoshi Nakatani; Toshikatsu Yagihara; Soichiro Kitamura
Journal:  J Thorac Cardiovasc Surg       Date:  2002-09       Impact factor: 5.209

Review 7.  Milestones in the management of atrial fibrillation.

Authors:  Joachim R Ehrlich; Stefan H Hohnloser
Journal:  Heart Rhythm       Date:  2009-09-01       Impact factor: 6.343

8.  Radiofrequency ablation of atrial fibrillation: the first 100 cases in Lyon.

Authors:  Philippe Chevalier; Mohamad Al Ghazzy; Léna Rivard; Christine Mestre; Brigitte De Breyne; Julien Pineau; Alexandre Guignier; Pierre Lavaud
Journal:  Int J Cardiol       Date:  2008-01-10       Impact factor: 4.164

9.  Characteristics of congestive heart failure accompanied by atrial fibrillation with special reference to tachycardia-induced cardiomyopathy.

Authors:  Tadashi Fujino; Takeshi Yamashita; Shinya Suzuki; Hiroaki Sugiyma; Koichi Sagara; Hitoshi Sawada; Tadanori Aizawa; Masaki Igarashi; Junichi Yamazaki
Journal:  Circ J       Date:  2007-06       Impact factor: 2.993

Review 10.  Surgical treatment of atrial fibrillation with concomitant mitral valve disease: an Asian review.

Authors:  Mien-Cheng Chen; Jen-Ping Chang; Yung-Lung Chen
Journal:  Chang Gung Med J       Date:  2008 Nov-Dec
View more
  3 in total

1.  A Rare Case of Bronchopericardial Fistula Following Atrial Fibrillation Ablation.

Authors:  Ghulam Murtaza; Daisy Young; Krishna Akella; Rakesh Gopinathannair; Dhanunjaya Lakkireddy; Alap Shah
Journal:  J Atr Fibrillation       Date:  2019-06-30

2.  Right phrenic nerve palsy following transcatheter radiofrequency current atrial fibrillation ablation: Case report.

Authors:  Gianmarco Abbadessa; Luigi Lavorgna; Giovanni Cirillo; Marinella Clerico; Vincenzo Todisco; Mario Cirillo; Francesca Trojsi; Gioacchino Tedeschi; Simona Bonavita
Journal:  J Int Med Res       Date:  2019-05-30       Impact factor: 1.671

3.  Initial outcome following invasive cardiac electrophysiologic studies and radiofrequency ablation of atrial fibrillation.

Authors:  Kelechukwu Uwanuruochi; Sabari Saravanan; Anita Ganasekar; Benjamin S Solomon; Ravikumar Murugesan; Ruchit A Shah; Jaishankar Krishnamoorthy; Ulhas M Pandurangi
Journal:  Int J Appl Basic Med Res       Date:  2016 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.